Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of RIG-I signaling pathway (GO:0039535) | 4.11464769 |
2 | COPII vesicle coating (GO:0048208) | 3.96138216 |
3 | proteasome assembly (GO:0043248) | 3.83636783 |
4 | lactate metabolic process (GO:0006089) | 3.72473470 |
5 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.61091498 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.57774514 |
7 | L-phenylalanine metabolic process (GO:0006558) | 3.57774514 |
8 | low-density lipoprotein particle clearance (GO:0034383) | 3.48310649 |
9 | purine nucleotide salvage (GO:0032261) | 3.44153245 |
10 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.43876235 |
11 | protein maturation by protein folding (GO:0022417) | 3.43282316 |
12 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.42557142 |
13 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.41555115 |
14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.29860235 |
15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.29860235 |
16 | tricarboxylic acid cycle (GO:0006099) | 3.24460159 |
17 | xenobiotic catabolic process (GO:0042178) | 3.24306086 |
18 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.12902726 |
19 | succinate metabolic process (GO:0006105) | 3.12559838 |
20 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.08677862 |
21 | desmosome organization (GO:0002934) | 3.04891555 |
22 | AMP metabolic process (GO:0046033) | 3.04463502 |
23 | regulation of hypersensitivity (GO:0002883) | 3.03324473 |
24 | regulation of mononuclear cell migration (GO:0071675) | 2.99560099 |
25 | respiratory chain complex IV assembly (GO:0008535) | 2.96895819 |
26 | cysteine metabolic process (GO:0006534) | 2.96214625 |
27 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.95886806 |
28 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.95415086 |
29 | L-phenylalanine catabolic process (GO:0006559) | 2.95415086 |
30 | mitochondrial calcium ion transport (GO:0006851) | 2.94595538 |
31 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.93994426 |
32 | natural killer cell mediated immunity (GO:0002228) | 2.93994426 |
33 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.93149350 |
34 | branched-chain amino acid catabolic process (GO:0009083) | 2.92257813 |
35 | positive regulation of interferon-alpha production (GO:0032727) | 2.90857392 |
36 | positive regulation of actin filament depolymerization (GO:0030836) | 2.89438545 |
37 | immunoglobulin mediated immune response (GO:0016064) | 2.89078897 |
38 | hemidesmosome assembly (GO:0031581) | 2.86216513 |
39 | regulation of cholesterol storage (GO:0010885) | 2.86027949 |
40 | cellular response to interferon-alpha (GO:0035457) | 2.85213649 |
41 | regulation of female gonad development (GO:2000194) | 2.78817089 |
42 | cellular response to virus (GO:0098586) | 2.74940899 |
43 | growth hormone receptor signaling pathway (GO:0060396) | 2.73896017 |
44 | negative regulation of lipid storage (GO:0010888) | 2.73884245 |
45 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.72142475 |
46 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.70850036 |
47 | regulation of interferon-alpha production (GO:0032647) | 2.70367272 |
48 | fibrinolysis (GO:0042730) | 2.68815473 |
49 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.65544705 |
50 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.64912918 |
51 | protein carboxylation (GO:0018214) | 2.64912918 |
52 | membrane budding (GO:0006900) | 2.64428297 |
53 | urate metabolic process (GO:0046415) | 2.61543590 |
54 | ribosome assembly (GO:0042255) | 2.61521320 |
55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.61413280 |
56 | cellular ketone body metabolic process (GO:0046950) | 2.61203153 |
57 | regulation of hexokinase activity (GO:1903299) | 2.61039959 |
58 | regulation of glucokinase activity (GO:0033131) | 2.61039959 |
59 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.60911036 |
60 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.60125065 |
61 | interferon-gamma secretion (GO:0072643) | 2.59800262 |
62 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.58782421 |
63 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.57658263 |
64 | NADH metabolic process (GO:0006734) | 2.55699924 |
65 | urea metabolic process (GO:0019627) | 2.54550808 |
66 | urea cycle (GO:0000050) | 2.54550808 |
67 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.54308231 |
68 | cytochrome complex assembly (GO:0017004) | 2.54201675 |
69 | regulation of metalloenzyme activity (GO:0048552) | 2.53926264 |
70 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.52972651 |
71 | regulation of sequestering of triglyceride (GO:0010889) | 2.51267084 |
72 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.50805870 |
73 | sulfur amino acid catabolic process (GO:0000098) | 2.50548275 |
74 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.50267335 |
75 | inositol phosphate dephosphorylation (GO:0046855) | 2.49360713 |
76 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.49360713 |
77 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.48633186 |
78 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.47022932 |
79 | purine-containing compound salvage (GO:0043101) | 2.46618542 |
80 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.46216764 |
81 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.46216764 |
82 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.45817997 |
83 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.45691197 |
84 | wound healing, spreading of cells (GO:0044319) | 2.44938861 |
85 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.44647743 |
86 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.44647743 |
87 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.44647743 |
88 | NIK/NF-kappaB signaling (GO:0038061) | 2.44307871 |
89 | branched-chain amino acid metabolic process (GO:0009081) | 2.43892597 |
90 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.43800383 |
91 | regulation of mitochondrial translation (GO:0070129) | 2.42970759 |
92 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.41864093 |
93 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.41864093 |
94 | lysine catabolic process (GO:0006554) | 2.41041889 |
95 | lysine metabolic process (GO:0006553) | 2.41041889 |
96 | organelle membrane fusion (GO:0090174) | 2.40799086 |
97 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.40785406 |
98 | negative regulation of ligase activity (GO:0051352) | 2.40785406 |
99 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.39908537 |
100 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.39531983 |
101 | amino-acid betaine metabolic process (GO:0006577) | 2.38708731 |
102 | positive regulation of humoral immune response (GO:0002922) | 2.37303520 |
103 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.36994020 |
104 | beta-amyloid metabolic process (GO:0050435) | 2.36808339 |
105 | valine metabolic process (GO:0006573) | 2.36379525 |
106 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.35767102 |
107 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.35767102 |
108 | protein autoprocessing (GO:0016540) | 2.35638527 |
109 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.35029889 |
110 | B cell mediated immunity (GO:0019724) | 2.34913074 |
111 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.34423641 |
112 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.33730796 |
113 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.33368612 |
114 | cellular response to growth hormone stimulus (GO:0071378) | 2.32170383 |
115 | inositol phosphate catabolic process (GO:0071545) | 2.32154740 |
116 | cell adhesion mediated by integrin (GO:0033627) | 2.32149560 |
117 | positive regulation of ligase activity (GO:0051351) | 2.31242909 |
118 | response to hydroperoxide (GO:0033194) | 2.30877637 |
119 | oxaloacetate metabolic process (GO:0006107) | 2.30851071 |
120 | regulation of B cell apoptotic process (GO:0002902) | 2.30788214 |
121 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.30783634 |
122 | sphingosine metabolic process (GO:0006670) | 2.30701826 |
123 | positive regulation of protein autophosphorylation (GO:0031954) | 2.30504913 |
124 | response to interferon-alpha (GO:0035455) | 2.29770910 |
125 | rRNA methylation (GO:0031167) | 2.28812832 |
126 | regulation of cellular amine metabolic process (GO:0033238) | 2.28172764 |
127 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.27876334 |
128 | fibroblast migration (GO:0010761) | 2.27731976 |
129 | positive regulation of p38MAPK cascade (GO:1900745) | 2.27526621 |
130 | ketone body metabolic process (GO:1902224) | 2.27344088 |
131 | rRNA modification (GO:0000154) | 2.27210443 |
132 | intestinal epithelial cell development (GO:0060576) | 2.27157242 |
133 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.27033280 |
134 | regulation of response to interferon-gamma (GO:0060330) | 2.26681915 |
135 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.26337188 |
136 | apoptotic cell clearance (GO:0043277) | 2.26127516 |
137 | positive regulation of interferon-beta production (GO:0032728) | 2.26055883 |
138 | sphingomyelin metabolic process (GO:0006684) | 2.25536551 |
139 | nitrogen cycle metabolic process (GO:0071941) | 2.25227128 |
140 | nitric oxide biosynthetic process (GO:0006809) | 2.24886615 |
141 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.24814900 |
142 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.23955191 |
143 | regulation of cholesterol homeostasis (GO:2000188) | 2.23933599 |
144 | positive regulation of macroautophagy (GO:0016239) | 2.23800778 |
145 | positive regulation of lipid storage (GO:0010884) | 2.23678586 |
146 | carnitine metabolic process (GO:0009437) | 2.23172839 |
147 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.22297449 |
148 | drug catabolic process (GO:0042737) | 2.21637324 |
149 | nucleoside salvage (GO:0043174) | 2.20342514 |
150 | complement activation, alternative pathway (GO:0006957) | 2.19775423 |
151 | heme biosynthetic process (GO:0006783) | 2.19474721 |
152 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.18865984 |
153 | fatty acid transmembrane transport (GO:1902001) | 2.18601943 |
154 | plasma lipoprotein particle clearance (GO:0034381) | 2.17734546 |
155 | regulation of protein activation cascade (GO:2000257) | 2.17651452 |
156 | fatty acid oxidation (GO:0019395) | 2.17162454 |
157 | vesicle coating (GO:0006901) | 2.16897598 |
158 | COPI coating of Golgi vesicle (GO:0048205) | 2.16720682 |
159 | Golgi transport vesicle coating (GO:0048200) | 2.16720682 |
160 | pteridine-containing compound metabolic process (GO:0042558) | 2.16641284 |
161 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.16522949 |
162 | regulation of complement activation (GO:0030449) | 2.15831924 |
163 | glycogen catabolic process (GO:0005980) | 2.15817411 |
164 | lipid oxidation (GO:0034440) | 2.15765268 |
165 | fatty acid beta-oxidation (GO:0006635) | 2.15439112 |
166 | myoblast migration (GO:0051451) | 2.15218067 |
167 | positive regulation of T cell apoptotic process (GO:0070234) | 2.15214740 |
168 | regulation of autophagic vacuole assembly (GO:2000785) | 2.15154677 |
169 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.15143485 |
170 | regulation of execution phase of apoptosis (GO:1900117) | 2.14917956 |
171 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.14075961 |
172 | membrane raft organization (GO:0031579) | 2.14047801 |
173 | sequestering of metal ion (GO:0051238) | 2.13696125 |
174 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.13668450 |
175 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.13042392 |
176 | response to growth hormone (GO:0060416) | 2.12880277 |
177 | skin morphogenesis (GO:0043589) | 2.12546683 |
178 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.10951255 |
179 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.10445737 |
180 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.10445737 |
181 | modulation by symbiont of host immune response (GO:0052553) | 2.10445737 |
182 | positive regulation by symbiont of host defense response (GO:0052509) | 2.10445737 |
183 | modulation by symbiont of host defense response (GO:0052031) | 2.10445737 |
184 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.10445737 |
185 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.09890794 |
186 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.09675904 |
187 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.09417735 |
188 | surfactant homeostasis (GO:0043129) | 2.09391587 |
189 | transcytosis (GO:0045056) | 2.08785633 |
190 | regulation of proton transport (GO:0010155) | 2.07669605 |
191 | serine family amino acid catabolic process (GO:0009071) | 2.07156415 |
192 | hepatocyte apoptotic process (GO:0097284) | 2.06526639 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.75678804 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.29487871 |
3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.01566222 |
4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.50697909 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.41895655 |
6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.33231196 |
7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.31425551 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.11322301 |
9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.04885193 |
10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.86253620 |
11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.85265988 |
12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.83919222 |
13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.68962203 |
14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.67824602 |
15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.46798929 |
16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.35562465 |
17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.35264250 |
18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.34453868 |
19 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.24813582 |
20 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.22654866 |
21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.18290185 |
22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.17060518 |
23 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.14859224 |
24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.14689695 |
25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.12162645 |
26 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.09775445 |
27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.06061144 |
28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.05303274 |
29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.98895271 |
30 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.98681088 |
31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.94709862 |
32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.87419789 |
33 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84905780 |
34 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.84707085 |
35 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.81000519 |
36 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80432446 |
37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.80120823 |
38 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.74858818 |
39 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.73681075 |
40 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.73238532 |
41 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.72598200 |
42 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.72022715 |
43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.70315071 |
44 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.70009086 |
45 | ATF3_27146783_Chip-Seq_COLON_Human | 1.68921943 |
46 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.68636870 |
47 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.66278633 |
48 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.65600321 |
49 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.64226295 |
50 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.61988961 |
51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.59144113 |
52 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.57242660 |
53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56838452 |
54 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.55076956 |
55 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.54133043 |
56 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53940425 |
57 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.53592528 |
58 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.52406089 |
59 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.51516532 |
60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49501795 |
61 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.47893613 |
62 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.45191865 |
63 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.45191865 |
64 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44772106 |
65 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.41779888 |
66 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.41560841 |
67 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.39880062 |
68 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.39498479 |
69 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39298372 |
70 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38015602 |
71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33325744 |
72 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32266967 |
73 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.30624288 |
74 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.29897477 |
75 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.29659206 |
76 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.29607914 |
77 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.28134991 |
78 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.27907208 |
79 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26568739 |
80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24664138 |
81 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.24053819 |
82 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.23467124 |
83 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.22489576 |
84 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.18864836 |
85 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.17764036 |
86 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.17500282 |
87 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.16551325 |
88 | CJUN_26792858_Chip-Seq_BT549_Human | 1.16332468 |
89 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.16227218 |
90 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.14662985 |
91 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.14629225 |
92 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13293728 |
93 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.13157861 |
94 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.13068273 |
95 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12528721 |
96 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.10341689 |
97 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.09981245 |
98 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.08789056 |
99 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.08698919 |
100 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.08566142 |
101 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.07315159 |
102 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.06657081 |
103 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.05379769 |
104 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05025777 |
105 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.04954891 |
106 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.04697284 |
107 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04550345 |
108 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04366010 |
109 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03973317 |
110 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.03700323 |
111 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01944511 |
112 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99689875 |
113 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99657072 |
114 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.99338961 |
115 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.98782131 |
116 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.96023087 |
117 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95640036 |
118 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.95320965 |
119 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.94726207 |
120 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94226423 |
121 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94043569 |
122 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.93532851 |
123 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.92505888 |
124 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.90443870 |
125 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90315526 |
126 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.90021490 |
127 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89049157 |
128 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.87937528 |
129 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.87880695 |
130 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.87352641 |
131 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.86524452 |
132 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.85162304 |
133 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83825969 |
134 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.83588673 |
135 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83001978 |
136 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.82294117 |
137 | MYB_26560356_Chip-Seq_TH2_Human | 0.81410356 |
138 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.81314532 |
139 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.80639099 |
140 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.79911560 |
141 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.79191842 |
142 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.78412508 |
143 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.78141532 |
144 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77986940 |
145 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.76553115 |
146 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.75953815 |
147 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.75381340 |
148 | GATA3_26560356_Chip-Seq_TH2_Human | 0.74850767 |
149 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.74702559 |
150 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.73632784 |
151 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.73462152 |
152 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.72780046 |
153 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72721183 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009780_abnormal_chondrocyte_physiolo | 3.22087633 |
2 | MP0002139_abnormal_hepatobiliary_system | 3.02620911 |
3 | MP0010234_abnormal_vibrissa_follicle | 2.96054853 |
4 | MP0003705_abnormal_hypodermis_morpholog | 2.73994179 |
5 | MP0002837_dystrophic_cardiac_calcinosis | 2.54161558 |
6 | MP0005451_abnormal_body_composition | 2.38640012 |
7 | MP0005379_endocrine/exocrine_gland_phen | 2.27690505 |
8 | MP0005360_urolithiasis | 2.24381302 |
9 | MP0006036_abnormal_mitochondrial_physio | 2.22886212 |
10 | MP0003566_abnormal_cell_adhesion | 2.22134164 |
11 | MP0002877_abnormal_melanocyte_morpholog | 2.19189385 |
12 | MP0009840_abnormal_foam_cell | 2.05369968 |
13 | MP0002138_abnormal_hepatobiliary_system | 2.01377111 |
14 | MP0003718_maternal_effect | 2.00255961 |
15 | MP0000013_abnormal_adipose_tissue | 1.99854348 |
16 | MP0005275_abnormal_skin_tensile | 1.93125390 |
17 | MP0003436_decreased_susceptibility_to | 1.92769112 |
18 | MP0003646_muscle_fatigue | 1.92667425 |
19 | MP0008875_abnormal_xenobiotic_pharmacok | 1.89183118 |
20 | MP0003724_increased_susceptibility_to | 1.88885502 |
21 | MP0010352_gastrointestinal_tract_polyps | 1.88710909 |
22 | MP0005365_abnormal_bile_salt | 1.87517209 |
23 | MP0002796_impaired_skin_barrier | 1.86770454 |
24 | MP0005085_abnormal_gallbladder_physiolo | 1.82556770 |
25 | MP0003453_abnormal_keratinocyte_physiol | 1.79998135 |
26 | MP0003191_abnormal_cellular_cholesterol | 1.77143227 |
27 | MP0002254_reproductive_system_inflammat | 1.74288867 |
28 | * MP0005464_abnormal_platelet_physiology | 1.72848021 |
29 | MP0004185_abnormal_adipocyte_glucose | 1.72032808 |
30 | MP0003186_abnormal_redox_activity | 1.70002875 |
31 | MP0009785_altered_susceptibility_to | 1.69457868 |
32 | MP0002163_abnormal_gland_morphology | 1.65528347 |
33 | MP0004947_skin_inflammation | 1.62987140 |
34 | MP0005058_abnormal_lysosome_morphology | 1.59751845 |
35 | MP0003806_abnormal_nucleotide_metabolis | 1.59431785 |
36 | MP0005023_abnormal_wound_healing | 1.57004543 |
37 | MP0001835_abnormal_antigen_presentation | 1.55479773 |
38 | * MP0002693_abnormal_pancreas_physiology | 1.54403650 |
39 | MP0001661_extended_life_span | 1.45321962 |
40 | MP0002876_abnormal_thyroid_physiology | 1.45254766 |
41 | MP0004782_abnormal_surfactant_physiolog | 1.44691027 |
42 | MP0003075_altered_response_to | 1.42757144 |
43 | MP0005165_increased_susceptibility_to | 1.41646432 |
44 | MP0005408_hypopigmentation | 1.40561160 |
45 | MP0002060_abnormal_skin_morphology | 1.39514857 |
46 | MP0003693_abnormal_embryo_hatching | 1.33227735 |
47 | MP0004510_myositis | 1.32042884 |
48 | MP0002909_abnormal_adrenal_gland | 1.30277504 |
49 | MP0005395_other_phenotype | 1.30152147 |
50 | MP0003656_abnormal_erythrocyte_physiolo | 1.29276545 |
51 | MP0008438_abnormal_cutaneous_collagen | 1.29125766 |
52 | * MP0001944_abnormal_pancreas_morphology | 1.27067902 |
53 | MP0010678_abnormal_skin_adnexa | 1.26584206 |
54 | MP0000685_abnormal_immune_system | 1.25897795 |
55 | MP0010329_abnormal_lipoprotein_level | 1.24743048 |
56 | MP0001533_abnormal_skeleton_physiology | 1.23258991 |
57 | MP0000343_altered_response_to | 1.22983319 |
58 | MP0000609_abnormal_liver_physiology | 1.22527810 |
59 | MP0003172_abnormal_lysosome_physiology | 1.22326571 |
60 | MP0003195_calcinosis | 1.21659679 |
61 | MP0006082_CNS_inflammation | 1.21036357 |
62 | MP0002148_abnormal_hypersensitivity_rea | 1.20106072 |
63 | MP0003786_premature_aging | 1.19677009 |
64 | MP0005636_abnormal_mineral_homeostasis | 1.19609217 |
65 | MP0002419_abnormal_innate_immunity | 1.18454119 |
66 | MP0001216_abnormal_epidermal_layer | 1.18405853 |
67 | MP0009764_decreased_sensitivity_to | 1.17645199 |
68 | MP0009643_abnormal_urine_homeostasis | 1.16822327 |
69 | MP0010386_abnormal_urinary_bladder | 1.16084212 |
70 | MP0006035_abnormal_mitochondrial_morpho | 1.16065112 |
71 | MP0005220_abnormal_exocrine_pancreas | 1.12927222 |
72 | MP0002006_tumorigenesis | 1.12446845 |
73 | MP0004264_abnormal_extraembryonic_tissu | 1.12132683 |
74 | MP0000858_altered_metastatic_potential | 1.11846618 |
75 | MP0005000_abnormal_immune_tolerance | 1.11311197 |
76 | MP0010368_abnormal_lymphatic_system | 1.11215971 |
77 | MP0003252_abnormal_bile_duct | 1.11143285 |
78 | MP0003303_peritoneal_inflammation | 1.11001287 |
79 | MP0005025_abnormal_response_to | 1.08969120 |
80 | MP0004019_abnormal_vitamin_homeostasis | 1.08390180 |
81 | MP0005319_abnormal_enzyme/_coenzyme | 1.08143976 |
82 | * MP0001845_abnormal_inflammatory_respons | 1.06463569 |
83 | MP0005501_abnormal_skin_physiology | 1.06054830 |
84 | MP0008469_abnormal_protein_level | 1.05000989 |
85 | MP0009697_abnormal_copulation | 1.04954618 |
86 | MP0003300_gastrointestinal_ulcer | 1.04884725 |
87 | MP0003091_abnormal_cell_migration | 1.04615890 |
88 | MP0005084_abnormal_gallbladder_morpholo | 1.04126012 |
89 | MP0004036_abnormal_muscle_relaxation | 1.03940263 |
90 | MP0000358_abnormal_cell_content/ | 1.03352183 |
91 | MP0002078_abnormal_glucose_homeostasis | 1.03310080 |
92 | MP0005310_abnormal_salivary_gland | 1.03214741 |
93 | MP0010155_abnormal_intestine_physiology | 1.02178088 |
94 | MP0001666_abnormal_nutrient_absorption | 1.01995422 |
95 | MP0006054_spinal_hemorrhage | 1.01942100 |
96 | MP0005330_cardiomyopathy | 1.01889298 |
97 | MP0008007_abnormal_cellular_replicative | 1.01746055 |
98 | MP0001545_abnormal_hematopoietic_system | 1.01735101 |
99 | MP0005397_hematopoietic_system_phenotyp | 1.01735101 |
100 | MP0003448_altered_tumor_morphology | 1.01718583 |
101 | MP0000003_abnormal_adipose_tissue | 1.01593209 |
102 | MP0003950_abnormal_plasma_membrane | 1.00160767 |
103 | MP0002090_abnormal_vision | 0.99482847 |
104 | MP0001756_abnormal_urination | 0.95984121 |
105 | MP0005387_immune_system_phenotype | 0.94686262 |
106 | MP0001790_abnormal_immune_system | 0.94686262 |
107 | MP0005332_abnormal_amino_acid | 0.92984447 |
108 | MP0008058_abnormal_DNA_repair | 0.92663923 |
109 | MP0002136_abnormal_kidney_physiology | 0.91402492 |
110 | MP0002452_abnormal_antigen_presenting | 0.90357381 |
111 | MP0009763_increased_sensitivity_to | 0.88806928 |
112 | MP0005083_abnormal_biliary_tract | 0.88513327 |
113 | MP0001764_abnormal_homeostasis | 0.87969571 |
114 | MP0010307_abnormal_tumor_latency | 0.87470969 |
115 | MP0001727_abnormal_embryo_implantation | 0.87193620 |
116 | MP0005666_abnormal_adipose_tissue | 0.87147757 |
117 | MP0002295_abnormal_pulmonary_circulatio | 0.86300414 |
118 | MP0002166_altered_tumor_susceptibility | 0.85760752 |
119 | MP0005075_abnormal_melanosome_morpholog | 0.85211788 |
120 | MP0000598_abnormal_liver_morphology | 0.84396020 |
121 | MP0005076_abnormal_cell_differentiation | 0.83938564 |
122 | MP0001800_abnormal_humoral_immune | 0.83254513 |
123 | MP0005535_abnormal_body_temperature | 0.83209973 |
124 | MP0003868_abnormal_feces_composition | 0.83138779 |
125 | MP0003045_fibrosis | 0.83018522 |
126 | MP0002723_abnormal_immune_serum | 0.81768065 |
127 | MP0000579_abnormal_nail_morphology | 0.81258935 |
128 | MP0002405_respiratory_system_inflammati | 0.81204032 |
129 | MP0002332_abnormal_exercise_endurance | 0.81085802 |
130 | * MP0001765_abnormal_ion_homeostasis | 0.80677761 |
131 | MP0005670_abnormal_white_adipose | 0.79789720 |
132 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.79407380 |
133 | MP0004130_abnormal_muscle_cell | 0.78987092 |
134 | MP0003763_abnormal_thymus_physiology | 0.78099111 |
135 | MP0005166_decreased_susceptibility_to | 0.77479218 |
136 | MP0001853_heart_inflammation | 0.77304486 |
137 | MP0004215_abnormal_myocardial_fiber | 0.76716713 |
138 | MP0002168_other_aberrant_phenotype | 0.76495575 |
139 | MP0002118_abnormal_lipid_homeostasis | 0.76126740 |
140 | MP0001243_abnormal_dermal_layer | 0.75758682 |
141 | MP0000627_abnormal_mammary_gland | 0.74959363 |
142 | MP0005167_abnormal_blood-brain_barrier | 0.74588276 |
143 | MP0001881_abnormal_mammary_gland | 0.74375679 |
144 | MP0001849_ear_inflammation | 0.72756834 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypokinesia (HP:0002375) | 3.55042345 |
2 | Deep venous thrombosis (HP:0002625) | 3.49083909 |
3 | Abnormality of glycolipid metabolism (HP:0010969) | 3.38863254 |
4 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.38863254 |
5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.38863254 |
6 | Right ventricular cardiomyopathy (HP:0011663) | 3.33856819 |
7 | Eczematoid dermatitis (HP:0000976) | 3.29415330 |
8 | Autoimmune thrombocytopenia (HP:0001973) | 3.19562165 |
9 | Myocardial infarction (HP:0001658) | 3.11622360 |
10 | Ketoacidosis (HP:0001993) | 3.08265722 |
11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.00321638 |
12 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.99165092 |
13 | Petechiae (HP:0000967) | 2.94065176 |
14 | Xanthomatosis (HP:0000991) | 2.93501532 |
15 | Palpitations (HP:0001962) | 2.93218596 |
16 | Tetraparesis (HP:0002273) | 2.87673063 |
17 | Progressive neurologic deterioration (HP:0002344) | 2.87655610 |
18 | Hypoglycemic seizures (HP:0002173) | 2.85668574 |
19 | Intrahepatic cholestasis (HP:0001406) | 2.82021179 |
20 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.82009283 |
21 | Male infertility (HP:0003251) | 2.74462914 |
22 | Tongue fasciculations (HP:0001308) | 2.71999815 |
23 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.67819614 |
24 | Hepatic necrosis (HP:0002605) | 2.65300189 |
25 | Esophageal varix (HP:0002040) | 2.62762843 |
26 | Recurrent bacterial skin infections (HP:0005406) | 2.54246017 |
27 | Systemic lupus erythematosus (HP:0002725) | 2.54184495 |
28 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51675602 |
29 | Type I transferrin isoform profile (HP:0003642) | 2.50699801 |
30 | Vascular calcification (HP:0004934) | 2.39639990 |
31 | Loss of speech (HP:0002371) | 2.38770943 |
32 | Abnormality of the common coagulation pathway (HP:0010990) | 2.38729963 |
33 | Interstitial pulmonary disease (HP:0006530) | 2.37999987 |
34 | Gout (HP:0001997) | 2.37812174 |
35 | Abnormality of purine metabolism (HP:0004352) | 2.37706982 |
36 | Recurrent abscess formation (HP:0002722) | 2.36860481 |
37 | Increased CSF protein (HP:0002922) | 2.36596245 |
38 | Muscle fibrillation (HP:0010546) | 2.36210679 |
39 | Dysostosis multiplex (HP:0000943) | 2.35954816 |
40 | Symptomatic seizures (HP:0011145) | 2.35161852 |
41 | Hypoglycemic coma (HP:0001325) | 2.34743116 |
42 | Orchitis (HP:0100796) | 2.33022092 |
43 | Hyperglycemia (HP:0003074) | 2.31047324 |
44 | Osteolytic defects of the hand bones (HP:0009699) | 2.29682796 |
45 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.29682796 |
46 | Increased connective tissue (HP:0009025) | 2.29518694 |
47 | Nausea (HP:0002018) | 2.27522683 |
48 | Hydroxyprolinuria (HP:0003080) | 2.27151693 |
49 | Abnormality of proline metabolism (HP:0010907) | 2.27151693 |
50 | Complement deficiency (HP:0004431) | 2.27019370 |
51 | Rhabdomyolysis (HP:0003201) | 2.25886918 |
52 | Hypoalphalipoproteinemia (HP:0003233) | 2.25340264 |
53 | Hepatocellular necrosis (HP:0001404) | 2.25091403 |
54 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.23283057 |
55 | Abnormal protein glycosylation (HP:0012346) | 2.23283057 |
56 | Abnormal glycosylation (HP:0012345) | 2.23283057 |
57 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.23283057 |
58 | Peritonitis (HP:0002586) | 2.22713904 |
59 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.21459244 |
60 | Steatorrhea (HP:0002570) | 2.20314286 |
61 | Vacuolated lymphocytes (HP:0001922) | 2.18655086 |
62 | Renal Fanconi syndrome (HP:0001994) | 2.18125170 |
63 | Abnormality of macrophages (HP:0004311) | 2.18044843 |
64 | Cardiovascular calcification (HP:0011915) | 2.18034830 |
65 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.17913461 |
66 | Malnutrition (HP:0004395) | 2.16715381 |
67 | Cortical dysplasia (HP:0002539) | 2.16026257 |
68 | Ankle contracture (HP:0006466) | 2.15708820 |
69 | Abnormality of complement system (HP:0005339) | 2.15060990 |
70 | Reduced antithrombin III activity (HP:0001976) | 2.14771489 |
71 | Polycythemia (HP:0001901) | 2.14395209 |
72 | Myositis (HP:0100614) | 2.14209198 |
73 | Progressive macrocephaly (HP:0004481) | 2.12221215 |
74 | Cervical subluxation (HP:0003308) | 2.11851449 |
75 | Abnormality of methionine metabolism (HP:0010901) | 2.11301040 |
76 | Vertebral compression fractures (HP:0002953) | 2.10146053 |
77 | Generalized aminoaciduria (HP:0002909) | 2.09948528 |
78 | Pustule (HP:0200039) | 2.09674287 |
79 | Plantar hyperkeratosis (HP:0007556) | 2.08181284 |
80 | Orthostatic hypotension (HP:0001278) | 2.05821569 |
81 | Protrusio acetabuli (HP:0003179) | 2.05402687 |
82 | Increased CSF lactate (HP:0002490) | 2.05282142 |
83 | Neonatal death (HP:0003811) | 2.04888367 |
84 | Mitochondrial inheritance (HP:0001427) | 2.04245725 |
85 | Thick nail (HP:0001805) | 2.04192348 |
86 | Abnormality of nucleobase metabolism (HP:0010932) | 2.03842386 |
87 | Ketosis (HP:0001946) | 2.03636922 |
88 | Dicarboxylic aciduria (HP:0003215) | 2.03625687 |
89 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.03625687 |
90 | Short nail (HP:0001799) | 2.03488340 |
91 | Hyperglycinuria (HP:0003108) | 2.03367988 |
92 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.02893394 |
93 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.02329387 |
94 | Large for gestational age (HP:0001520) | 2.00059042 |
95 | Acute necrotizing encephalopathy (HP:0006965) | 1.99420819 |
96 | Glucose intolerance (HP:0000833) | 1.99235198 |
97 | Myoglobinuria (HP:0002913) | 1.98861224 |
98 | Neuroendocrine neoplasm (HP:0100634) | 1.98513307 |
99 | Abnormal cartilage morphology (HP:0002763) | 1.95926578 |
100 | Prolonged neonatal jaundice (HP:0006579) | 1.95407663 |
101 | Abnormality of vitamin metabolism (HP:0100508) | 1.94917065 |
102 | Nemaline bodies (HP:0003798) | 1.94602634 |
103 | Alopecia of scalp (HP:0002293) | 1.94319006 |
104 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.93968224 |
105 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.93968224 |
106 | Hamartoma of the eye (HP:0010568) | 1.93797474 |
107 | Abnormality of the intrinsic pathway (HP:0010989) | 1.93759990 |
108 | Hyperammonemia (HP:0001987) | 1.93726501 |
109 | Neoplasm of the adrenal gland (HP:0100631) | 1.93321258 |
110 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.92031339 |
111 | Increased cerebral lipofuscin (HP:0011813) | 1.90270024 |
112 | Distal lower limb muscle weakness (HP:0009053) | 1.90143650 |
113 | Abnormality of vitamin B metabolism (HP:0004340) | 1.89656205 |
114 | Degeneration of anterior horn cells (HP:0002398) | 1.87096886 |
115 | Abnormality of the anterior horn cell (HP:0006802) | 1.87096886 |
116 | Nephritis (HP:0000123) | 1.87094640 |
117 | Abnormality of glycolysis (HP:0004366) | 1.86431566 |
118 | Respiratory failure (HP:0002878) | 1.85726409 |
119 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84283179 |
120 | Arterial thrombosis (HP:0004420) | 1.84271554 |
121 | Hypolipoproteinemia (HP:0010981) | 1.84227379 |
122 | Insulin resistance (HP:0000855) | 1.84205467 |
123 | Diminished movement (HP:0002374) | 1.83798569 |
124 | Acute encephalopathy (HP:0006846) | 1.83774810 |
125 | Hyperthyroidism (HP:0000836) | 1.83181123 |
126 | Palmoplantar hyperkeratosis (HP:0000972) | 1.82560691 |
127 | Proximal tubulopathy (HP:0000114) | 1.81629387 |
128 | Cholecystitis (HP:0001082) | 1.81627762 |
129 | Gastrointestinal infarctions (HP:0005244) | 1.81376689 |
130 | Abnormal gallbladder morphology (HP:0012437) | 1.80740668 |
131 | Abnormality of iron homeostasis (HP:0011031) | 1.80460765 |
132 | Increased IgE level (HP:0003212) | 1.80125416 |
133 | Increased intramyocellular lipid droplets (HP:0012240) | 1.80087687 |
134 | 3-Methylglutaconic aciduria (HP:0003535) | 1.79557438 |
135 | Abnormality of the basal ganglia (HP:0002134) | 1.79396172 |
136 | Methylmalonic acidemia (HP:0002912) | 1.79128775 |
137 | Ulnar deviation of the wrist (HP:0003049) | 1.79044949 |
138 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.78530186 |
139 | Cardiomegaly (HP:0001640) | 1.78438534 |
140 | Fatigue (HP:0012378) | 1.78233557 |
141 | Acanthosis nigricans (HP:0000956) | 1.77321543 |
142 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.77294235 |
143 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.77294235 |
144 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.77294235 |
145 | Increased serum pyruvate (HP:0003542) | 1.76791054 |
146 | Fat malabsorption (HP:0002630) | 1.76732100 |
147 | Lower limb hyperreflexia (HP:0002395) | 1.76713469 |
148 | Hematochezia (HP:0002573) | 1.75856550 |
149 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.75543945 |
150 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.75543945 |
151 | Asymmetric septal hypertrophy (HP:0001670) | 1.75339976 |
152 | Abnormal hemoglobin (HP:0011902) | 1.75335702 |
153 | Increased purine levels (HP:0004368) | 1.74159427 |
154 | Hyperuricemia (HP:0002149) | 1.74159427 |
155 | Axonal loss (HP:0003447) | 1.73915484 |
156 | Lactic acidosis (HP:0003128) | 1.73875377 |
157 | Beaking of vertebral bodies (HP:0004568) | 1.73607902 |
158 | Mucopolysacchariduria (HP:0008155) | 1.72096985 |
159 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.72096985 |
160 | Prolonged partial thromboplastin time (HP:0003645) | 1.71889449 |
161 | Pancreatitis (HP:0001733) | 1.71581359 |
162 | Metaphyseal dysplasia (HP:0100255) | 1.71071637 |
163 | Lethargy (HP:0001254) | 1.71038032 |
164 | Optic neuritis (HP:0100653) | 1.70427363 |
165 | Retrobulbar optic neuritis (HP:0100654) | 1.70427363 |
166 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.70290057 |
167 | Increased muscle lipid content (HP:0009058) | 1.70224179 |
168 | Conjunctival hamartoma (HP:0100780) | 1.70172185 |
169 | Epidermoid cyst (HP:0200040) | 1.69009096 |
170 | Anorexia (HP:0002039) | 1.68699893 |
171 | Pheochromocytoma (HP:0002666) | 1.68594750 |
172 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.67639706 |
173 | Increased mean platelet volume (HP:0011877) | 1.67566198 |
174 | Lipid accumulation in hepatocytes (HP:0006561) | 1.67530171 |
175 | Exercise-induced myalgia (HP:0003738) | 1.67109689 |
176 | Premature rupture of membranes (HP:0001788) | 1.66990993 |
177 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.66932999 |
178 | Milia (HP:0001056) | 1.66651760 |
179 | Hepatocellular carcinoma (HP:0001402) | 1.66313624 |
180 | Difficulty climbing stairs (HP:0003551) | 1.65956781 |
181 | Multiple enchondromatosis (HP:0005701) | 1.64457451 |
182 | Onycholysis (HP:0001806) | 1.64232447 |
183 | Hemorrhage of the eye (HP:0011885) | 1.63816315 |
184 | Abnormal gallbladder physiology (HP:0012438) | 1.63793971 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EIF2AK3 | 3.25287920 |
2 | MAPKAPK3 | 2.86721923 |
3 | MOS | 2.75567756 |
4 | SCYL2 | 2.68343382 |
5 | TAOK3 | 2.60806796 |
6 | MAP3K13 | 2.54410138 |
7 | KSR2 | 2.47560154 |
8 | ARAF | 2.31481839 |
9 | LATS1 | 2.29748678 |
10 | TRIB3 | 2.24208999 |
11 | ERN1 | 2.23292010 |
12 | EEF2K | 2.08967308 |
13 | LATS2 | 2.05792353 |
14 | PHKG1 | 2.01828062 |
15 | PHKG2 | 2.01828062 |
16 | ERBB4 | 1.97471137 |
17 | TBK1 | 1.89955348 |
18 | TYK2 | 1.86817900 |
19 | MAP3K3 | 1.85737302 |
20 | STK38L | 1.83544225 |
21 | TESK1 | 1.83388950 |
22 | MYLK | 1.77310590 |
23 | MAP3K14 | 1.76660595 |
24 | BMPR2 | 1.75678151 |
25 | NEK9 | 1.72977085 |
26 | STK10 | 1.70164424 |
27 | MAP3K9 | 1.68392863 |
28 | MST1R | 1.65610750 |
29 | PKN2 | 1.63061568 |
30 | MAP3K6 | 1.61009358 |
31 | TAOK1 | 1.60481793 |
32 | BUB1 | 1.59705897 |
33 | STK3 | 1.57353453 |
34 | FRK | 1.47487113 |
35 | TRPM7 | 1.46173617 |
36 | PLK4 | 1.44976619 |
37 | ABL2 | 1.44585585 |
38 | BRAF | 1.43162232 |
39 | PIM2 | 1.43084106 |
40 | LRRK2 | 1.40287666 |
41 | JAK3 | 1.39643587 |
42 | RAF1 | 1.36816760 |
43 | EPHA2 | 1.30742017 |
44 | NME2 | 1.30406821 |
45 | STK16 | 1.29958044 |
46 | STK24 | 1.27304021 |
47 | TTN | 1.22406846 |
48 | TTK | 1.21463239 |
49 | LIMK1 | 1.20483858 |
50 | FGFR4 | 1.19621309 |
51 | ERBB3 | 1.18105223 |
52 | RPS6KB2 | 1.17872611 |
53 | EPHA3 | 1.16988738 |
54 | LMTK2 | 1.15240051 |
55 | RPS6KA4 | 1.12946206 |
56 | BCKDK | 1.11561874 |
57 | DAPK1 | 1.10806227 |
58 | MAP2K6 | 1.10304205 |
59 | IKBKE | 1.10082840 |
60 | JAK1 | 1.09595739 |
61 | MAP3K2 | 1.06378987 |
62 | IRAK3 | 1.01961462 |
63 | MAP2K1 | 1.01643849 |
64 | TRIM28 | 1.00870575 |
65 | MAP3K1 | 1.00607646 |
66 | MAP3K11 | 1.00315396 |
67 | FER | 0.99717054 |
68 | IKBKB | 0.92813576 |
69 | JAK2 | 0.90824960 |
70 | MAP3K8 | 0.89892978 |
71 | FLT3 | 0.89711396 |
72 | RIPK1 | 0.88619498 |
73 | MAP3K5 | 0.88255978 |
74 | NLK | 0.88204189 |
75 | MAP2K3 | 0.86478021 |
76 | MST4 | 0.81683175 |
77 | KIT | 0.80849393 |
78 | PTK2B | 0.78746138 |
79 | CHUK | 0.78585957 |
80 | MAP3K12 | 0.77686506 |
81 | VRK2 | 0.77338003 |
82 | ACVR1B | 0.76292300 |
83 | CAMK2D | 0.72852176 |
84 | ILK | 0.72748063 |
85 | PTK6 | 0.72294248 |
86 | CDK9 | 0.72137662 |
87 | ZAK | 0.71560228 |
88 | RIPK4 | 0.71500296 |
89 | NEK1 | 0.69937436 |
90 | TGFBR2 | 0.69782817 |
91 | NUAK1 | 0.68541253 |
92 | PIM1 | 0.68139598 |
93 | NME1 | 0.67825420 |
94 | IRAK1 | 0.66766119 |
95 | PIK3CG | 0.66328042 |
96 | CSNK1G1 | 0.64882095 |
97 | ZAP70 | 0.64824952 |
98 | EIF2AK2 | 0.64568842 |
99 | PLK3 | 0.64492605 |
100 | OBSCN | 0.63975814 |
101 | RET | 0.63859427 |
102 | MATK | 0.63350078 |
103 | PTK2 | 0.62621768 |
104 | CSNK1G3 | 0.61195435 |
105 | STK4 | 0.60592587 |
106 | KDR | 0.60026122 |
107 | MUSK | 0.58714036 |
108 | MAPK11 | 0.58013127 |
109 | SIK3 | 0.57401243 |
110 | MELK | 0.57386832 |
111 | GRK1 | 0.57160808 |
112 | FGFR3 | 0.55532334 |
113 | TEC | 0.53812519 |
114 | PRKCI | 0.53662070 |
115 | HIPK2 | 0.51629426 |
116 | TXK | 0.51003068 |
117 | TIE1 | 0.50781728 |
118 | TSSK6 | 0.48588516 |
119 | DAPK3 | 0.48174550 |
120 | PDK2 | 0.48031068 |
121 | PRKAA2 | 0.47587987 |
122 | BMX | 0.46851570 |
123 | PINK1 | 0.46002045 |
124 | TGFBR1 | 0.45332293 |
125 | PAK4 | 0.45096933 |
126 | CAMK2G | 0.44514632 |
127 | CDK6 | 0.41900223 |
128 | MET | 0.39740618 |
129 | ABL1 | 0.38781600 |
130 | DAPK2 | 0.38652703 |
131 | PAK1 | 0.37882469 |
132 | PBK | 0.36466193 |
133 | DMPK | 0.34964113 |
134 | EPHB1 | 0.34938121 |
135 | PRKCE | 0.34002856 |
136 | TAOK2 | 0.33748280 |
137 | NEK2 | 0.32614773 |
138 | EIF2AK1 | 0.32545076 |
139 | PASK | 0.32524226 |
140 | TESK2 | 0.32242788 |
141 | MAP4K1 | 0.32202578 |
142 | CSK | 0.32109216 |
143 | MAPKAPK2 | 0.31693204 |
144 | PRKG2 | 0.31646382 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 3.92963698 |
2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.06328195 |
3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.00767827 |
4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.77719469 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.67695194 |
6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.61750025 |
7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.44887958 |
8 | Protein export_Homo sapiens_hsa03060 | 2.40653853 |
9 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.32753073 |
10 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.14542342 |
11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.94118520 |
12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.93091546 |
13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.87652636 |
14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.85190252 |
15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.74296433 |
16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.68605900 |
17 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.67745219 |
18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.63410191 |
19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.54784371 |
20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.52568504 |
21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.52296091 |
22 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.45319698 |
23 | Legionellosis_Homo sapiens_hsa05134 | 1.43799141 |
24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.40979277 |
25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.39570074 |
26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.39036555 |
27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.35388848 |
28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.33117612 |
29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32820552 |
30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32461617 |
31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.30361043 |
32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.29705281 |
33 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.28506681 |
34 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.27408704 |
35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26387402 |
36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.25923330 |
37 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.24024578 |
38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.19007926 |
39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.15878937 |
40 | Lysosome_Homo sapiens_hsa04142 | 1.13836816 |
41 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.13058678 |
42 | Histidine metabolism_Homo sapiens_hsa00340 | 1.12984035 |
43 | Amoebiasis_Homo sapiens_hsa05146 | 1.12872607 |
44 | Apoptosis_Homo sapiens_hsa04210 | 1.12815196 |
45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.12706831 |
46 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.12571866 |
47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11441838 |
48 | Influenza A_Homo sapiens_hsa05164 | 1.11416430 |
49 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.11246758 |
50 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.10837476 |
51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.09172199 |
52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.08689668 |
53 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.08438089 |
54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.07939348 |
55 | Mismatch repair_Homo sapiens_hsa03430 | 1.07165806 |
56 | Malaria_Homo sapiens_hsa05144 | 1.06072857 |
57 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.05906576 |
58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.04508204 |
59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.04185299 |
60 | Pertussis_Homo sapiens_hsa05133 | 1.00849602 |
61 | Thyroid cancer_Homo sapiens_hsa05216 | 0.99532851 |
62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.98716058 |
63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.98422471 |
64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.97832991 |
65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.95181460 |
66 | Peroxisome_Homo sapiens_hsa04146 | 0.94057273 |
67 | Tuberculosis_Homo sapiens_hsa05152 | 0.93491869 |
68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.92255844 |
69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91710834 |
70 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.91440721 |
71 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.91294309 |
72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.91205200 |
73 | Shigellosis_Homo sapiens_hsa05131 | 0.90682076 |
74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.89449303 |
75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89403854 |
76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89006078 |
77 | Adherens junction_Homo sapiens_hsa04520 | 0.88533587 |
78 | Parkinsons disease_Homo sapiens_hsa05012 | 0.86233165 |
79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.85635661 |
80 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85448209 |
81 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83458851 |
82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83148051 |
83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.83045025 |
84 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.82754264 |
85 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.82468467 |
86 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.82246126 |
87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.81874677 |
88 | Insulin resistance_Homo sapiens_hsa04931 | 0.81860770 |
89 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80044025 |
90 | Bladder cancer_Homo sapiens_hsa05219 | 0.79827323 |
91 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.79191862 |
92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79052976 |
93 | Measles_Homo sapiens_hsa05162 | 0.78557710 |
94 | Allograft rejection_Homo sapiens_hsa05330 | 0.78405434 |
95 | Hepatitis C_Homo sapiens_hsa05160 | 0.76807685 |
96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74906051 |
97 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.73857626 |
98 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.73738848 |
99 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73693060 |
100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.72720746 |
101 | Carbon metabolism_Homo sapiens_hsa01200 | 0.72707393 |
102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71326201 |
103 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70985519 |
104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.70809719 |
105 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.69689428 |
106 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.69615169 |
107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68110044 |
108 | Hepatitis B_Homo sapiens_hsa05161 | 0.66417656 |
109 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63350299 |
110 | Retinol metabolism_Homo sapiens_hsa00830 | 0.63148515 |
111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62960192 |
112 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.62512160 |
113 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.62409768 |
114 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.61606609 |
115 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61577402 |
116 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.61136472 |
117 | Phagosome_Homo sapiens_hsa04145 | 0.59393915 |
118 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59263270 |
119 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59257507 |
120 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58114131 |
121 | Purine metabolism_Homo sapiens_hsa00230 | 0.58059559 |
122 | Salmonella infection_Homo sapiens_hsa05132 | 0.57868471 |
123 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.57832626 |
124 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.56865470 |
125 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56772415 |
126 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.56657760 |
127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55049964 |
128 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.54752071 |
129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54417837 |
130 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.54347151 |
131 | Alzheimers disease_Homo sapiens_hsa05010 | 0.54314202 |
132 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.53918216 |
133 | Bile secretion_Homo sapiens_hsa04976 | 0.53868340 |
134 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.52226232 |
135 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51066974 |
136 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50777021 |
137 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50695607 |
138 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50550067 |
139 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.50200168 |
140 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45408776 |
141 | Mineral absorption_Homo sapiens_hsa04978 | 0.40802969 |
142 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40054640 |
143 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38379984 |
144 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37507356 |
145 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.33699420 |
146 | RNA polymerase_Homo sapiens_hsa03020 | 0.30251322 |
147 | RNA degradation_Homo sapiens_hsa03018 | 0.29973208 |